CES 2022: Defying Omicron, World’s Biggest Tech Show Goes Live In Las Vegas
Executive Summary
CES 2022 is missing some marquee names due to the coronavirus surge, but there’s still plenty to take in at the intersection of digital health and consumer tech. In this roundup, Medtech Insight highlights some standouts, with commentary from company leaders.
You may also be interested in...
FDA Draft Guidance Paves Way For Collecting Clinical Study Data Via Digital Health Technologies
The US FDA released draft guidance on how device makers, investigators and other stakeholders can use digital health solutions to collect data from clinical study participants remotely. Comments are due to the agency by 22 March 2022.
‘Training People To Be Healthier’: Digital Therapeutics Programmed For Growth
Experts foresee the digital therapeutics market growing to $6bn-$9bn by 2025, driven in part by tech-empowered consumers and patients looking for solutions to better manage their own health and conditions. For medtechs, collaborations with software-driven start-ups will be key to harnessing personalized data and differentiating themselves in the marketplace.
Financing Quarterly Statistics: Q1 Highlights Include 3 Medtech And 7 IVD IPOs
To open the year, medical device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $7bn.